470 related articles for article (PubMed ID: 9184696)
1. The apoptosis and proliferation of SAC-activated B cells by IL-10 are associated with changes in Bcl-2, Bcl-xL, and Mcl-1 expression.
Li L; Krajewski S; Reed JC; Choi YS
Cell Immunol; 1997 May; 178(1):33-41. PubMed ID: 9184696
[TBL] [Abstract][Full Text] [Related]
2. Regulation of bcl-2, bcl-XL and bax in the control of apoptosis by hematopoietic cytokines and dexamethasone.
Lotem J; Sachs L
Cell Growth Differ; 1995 Jun; 6(6):647-53. PubMed ID: 7669718
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-2 receptor common gamma-chain signaling cytokines regulate activated T cell apoptosis in response to growth factor withdrawal: selective induction of anti-apoptotic (bcl-2, bcl-xL) but not pro-apoptotic (bax, bcl-xS) gene expression.
Akbar AN; Borthwick NJ; Wickremasinghe RG; Panayoitidis P; Pilling D; Bofill M; Krajewski S; Reed JC; Salmon M
Eur J Immunol; 1996 Feb; 26(2):294-9. PubMed ID: 8617294
[TBL] [Abstract][Full Text] [Related]
4. APO-1 mediated apoptosis or proliferation in human chronic B lymphocytic leukemia: correlation with bcl-2 oncogene expression.
Mapara MY; Bargou R; Zugck C; Döhner H; Ustaoglu F; Jonker RR; Krammer PH; Dörken B
Eur J Immunol; 1993 Mar; 23(3):702-8. PubMed ID: 7680614
[TBL] [Abstract][Full Text] [Related]
5. Expression of bcl-x during mouse B cell differentiation and following activation by various stimuli.
Choi MS; Holmann M; Atkins CJ; Klaus GG
Eur J Immunol; 1996 Mar; 26(3):676-82. PubMed ID: 8605937
[TBL] [Abstract][Full Text] [Related]
6. Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas.
Krajewska M; Moss SF; Krajewski S; Song K; Holt PR; Reed JC
Cancer Res; 1996 May; 56(10):2422-7. PubMed ID: 8625322
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of Bcl-xL expression protects CD40-activated human B cells from Fas-mediated apoptosis.
Zhang X; Li L; Choe J; Krajewski S; Reed JC; Thompson C; Choi YS
Cell Immunol; 1996 Oct; 173(1):149-54. PubMed ID: 8871610
[TBL] [Abstract][Full Text] [Related]
8. BCL-2 family expression in human neutrophils during delayed and accelerated apoptosis.
Moulding DA; Akgul C; Derouet M; White MR; Edwards SW
J Leukoc Biol; 2001 Nov; 70(5):783-92. PubMed ID: 11698499
[TBL] [Abstract][Full Text] [Related]
9. GM-CSF rescues TF-1 cells from growth factor withdrawal-induced, but not differentiation-induced apoptosis: the role of BCL-2 and MCL-1.
Klampfer L; Zhang J; Nimer SD
Cytokine; 1999 Nov; 11(11):849-55. PubMed ID: 10547272
[TBL] [Abstract][Full Text] [Related]
10. Bcl-XL induction during terminal differentiation of friend erythroleukaemia cells correlates with delay of apoptosis and loss of proliferative capacity but not with haemoglobinization.
Hafid-Medheb K; Poindessous-Jazat V; Augery-Bourget Y; Hanania N; Robert-Lézénès J
Cell Death Differ; 1999 Feb; 6(2):166-74. PubMed ID: 10200563
[TBL] [Abstract][Full Text] [Related]
11. Role of Bax in apoptosis of IL-3-dependent cells.
Low W; Olmos-Centenera G; Madsen C; Leverrier Y; Collins MK
Oncogene; 2001 Jul; 20(33):4476-83. PubMed ID: 11494143
[TBL] [Abstract][Full Text] [Related]
12. Influence of Bax or Bcl-2 overexpression on the ceramide-dependent apoptotic pathway in glioma cells.
Sawada M; Nakashima S; Banno Y; Yamakawa H; Takenaka K; Shinoda J; Nishimura Y; Sakai N; Nozawa Y
Oncogene; 2000 Jul; 19(31):3508-20. PubMed ID: 10918609
[TBL] [Abstract][Full Text] [Related]
13. Expression of the Bcl-2 homologue Mcl-1 correlates with survival of peripheral blood B lymphocytes.
Lømo J; Smeland EB; Krajewski S; Reed JC; Blomhoff HK
Cancer Res; 1996 Jan; 56(1):40-3. PubMed ID: 8548771
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor-beta-mediated apoptosis in the Ramos B-lymphoma cell line is accompanied by caspase activation and Bcl-XL downregulation.
Saltzman A; Munro R; Searfoss G; Franks C; Jaye M; Ivashchenko Y
Exp Cell Res; 1998 Jul; 242(1):244-54. PubMed ID: 9665822
[TBL] [Abstract][Full Text] [Related]
15. The role of IL-10 in human B cell activation, proliferation, and differentiation.
Itoh K; Hirohata S
J Immunol; 1995 May; 154(9):4341-50. PubMed ID: 7722292
[TBL] [Abstract][Full Text] [Related]
16. Expression of Bcl-2, Bcl-x, and Bax after T cell activation and IL-2 withdrawal.
Broome HE; Dargan CM; Krajewski S; Reed JC
J Immunol; 1995 Sep; 155(5):2311-7. PubMed ID: 7650367
[TBL] [Abstract][Full Text] [Related]
17. Germinal center-derived signals act with Bcl-2 to decrease apoptosis and increase clonogenicity of drug-treated human B lymphoma cells.
Walker A; Taylor ST; Hickman JA; Dive C
Cancer Res; 1997 May; 57(10):1939-45. PubMed ID: 9157989
[TBL] [Abstract][Full Text] [Related]
18. Induction of T cell clonal anergy results in resistance, whereas CD28-mediated costimulation primes for susceptibility to Fas- and Bax-mediated programmed cell death.
Boussiotis VA; Lee BJ; Freeman GJ; Gribben JG; Nadler LM
J Immunol; 1997 Oct; 159(7):3156-67. PubMed ID: 9317113
[TBL] [Abstract][Full Text] [Related]
19. Strength of signal through BCR determines the fate of cycling B cells by regulating the expression of the Bcl-2 family of survival proteins.
Pittner BT; Snow EC
Cell Immunol; 1998 May; 186(1):55-62. PubMed ID: 9637765
[TBL] [Abstract][Full Text] [Related]
20. Activation of the cAMP signaling pathway increases apoptosis in human B-precursor cells and is associated with downregulation of Mcl-1 expression.
Myklebust JH; Josefsen D; Blomhoff HK; Levy FO; Naderi S; Reed JC; Smeland EB
J Cell Physiol; 1999 Jul; 180(1):71-80. PubMed ID: 10362019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
